BioNTech and Pfizer's COVID-19 vaccine shows potential in human trial - Reuters UK

12:17pm PDT - July 1st, 2020    novavax stock - Reuters

A COVID-19 vaccine developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer has shown potential and was found to be well tolerated in early-stage human trials, the companies said on Wednesday.